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Abstract The S1235R locus in CFTR was studied in combina-
tion with alleles found at the M470V and G628R loci. While
R628 caused a maturational defect, R1235 did not. The impact of
R1235 was found to be influenced by the alleles present at the
G628R and M470V loci. At the single channel level, R1235-V
(R1235 on a V470 background) was characterized by an open
probability significantly higher than V470-wildtype CFTR.
M470, which on its own increases CFTR chloride transport
activity when compared to V470-wildtype CFTR, suppressed the
activity of R1235 in such a way that a protein with an open
probability not significantly different from V470-wildtype CFTR
was obtained. While R628-V CFTR had similar current densities
as V470-wildtype CFTR in Xenopus laevis oocytes, R1235-V
resulted in current densities that were more than twofold higher
than those of V470-wildtype CFTR. However, the current
densities generated by R1235/R628-V (R1235 and R628 on a
V470 background) CFTR were significant lower than R1235-V
or R628-V CFTR.
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1. Introduction
The CFTR gene encodes a cAMP and ATP dependent chlo-
ride channel that is present in the apical membrane of epithe-
lial cells lining most exocrine glands [1]. Phosphorylation of
the regulatory domain by protein kinase A, followed by bind-
ing and hydrolysis of ATP at both nucleotide binding do-
mains, regulates the transport of chloride ions through the
channel [2]. Absence, reduced levels, or malfunction of the
CFTR protein results in cystic ¢brosis, and diseases such as
CBAVD (congenital bilateral absence of the vas deferens)
[3,4], bronchiectasis [5] and chronic pancreatitis [6]. Since
the discovery of the CFTR gene [7], more than 850 mutations
and 120 polymorphisms have been identi¢ed ([8], CF Genetic
Analysis Consortium; URL: http://www.genet.sickkids.on.
ca). The majority of these mutations are rare and the relation
to disease is not always clear. The S1235R amino acid alter-
ation is such a mutation. It was ¢rst found in a cystic ¢brosis
(CF) patient who carried S1235R and G628R (gCc) on the
same allele [9]. In compound heterozygosity with a severe
mutation, the S1235R amino acid alteration alone might
also result in disease. However, varying degrees of symptoms
are seen in the latter individuals, some of them are even un-
a¡ected. The partial penetrance of a mutation might be ex-
plained by polymorphisms [10,11], since the presence of poly-
morphisms on the same allele may interfere with, or mask, the
functional defects caused by a particular amino acid altera-
tion. For the M470V locus, we have shown that the two
alleles interfere both with the processing and with the chloride
transport activity of the CFTR protein [11]. In order to get
better insight into the e¡ect of the S1235R mutation, on dif-
ferent backgrounds, the maturational pattern and the electro-
physiological properties of these mutant proteins were deter-
mined.
2. Materials and methods
2.1. Characterization of alleles at polymorphic loci
Screening for the alleles at the (TG)m (located in intron 8), Tn
(located in intron 8), M470V and S1235R loci was performed as
previously described [9,11].
2.2. Construction of mutants
A XhoI^KpnI fragment containing the CFTR coding region was
isolated from the prokaryotic vector pTG5960 (Transgene S.A., Stras-
bourg, France) and inserted in the eukaryotic expression vector
pcDNA3 (Invitrogen BV, Leek, The Netherlands). In order to remove
a potential ATG start codon derived from the multiple cloning site of
pTG5960, the construct was digested with KpnI and EcoRV and the
resulting linear plasmid was blunt-end ligated after T4 DNA polymer-
ase treatment. The CFTR coding region present in the resulting con-
struct was characterized by dideoxy sequencing and one polymor-
phism, V470, was identi¢ed. The sequence also contained three
neutral amino acid changes (t930c, a933g and t936c) that had been
introduced in order to inactivate a cryptic prokaryotic promoter [12].
The di¡erent amino acid alterations, V470M, G628R and S1235R,
were introduced using the Transformer Site-Directed Mutagenesis
kit (Clontech Laboratories, Inc., Palo Alto, CA, USA). The complete
CFTR coding region of the di¡erent mutants was sequenced; no other
mutations than the desired ones were found.
For single channel measurements, the di¡erent mutants and wild-
type CFTR cDNAs were transferred to the bicistronic green £uores-
cent protein (GFP) expression vector pCINeo/IRES-GFP [13]. For
this purpose, wildtype CFTR cDNA derived from pcDNA3-CFTR
was ligated as a T4 DNA polymerase treated XhoI^SacI fragment
in pCINeo/IRES-GFP. The latter had ¢rst been linearized with
NheI, blunt-ended with T4 DNA polymerase and dephosphorylated
with bovine alkaline phosphatase. The region harboring the di¡erent
studied mutations was subsequently removed from pCINeo/wtCFTR-
IRES-GFP by complete digestion with XbaI and partial digestion
with BstXI and was replaced by the corresponding mutant CFTR
fragments that had been obtained by complete digestion of the di¡er-
ent mutant pcDNA3-CFTR constructs with XbaI and BstXI.
2.3. Expression, pulse chase and immunoprecipitation of CFTR
The expression of mutant CFTR proteins, pulse chase and immu-
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 5 1 9 - 2
*Corresponding author. Fax: (32)-16-345997.
E-mail: harry.cuppens@med.kuleuven.ac.be
FEBS 23652 8-5-00
FEBS 23652 FEBS Letters 473 (2000) 149^153
noprecipitation experiments of CFTR were performed as previously
described [14].
2.4. Physiological studies
In vitro transcription of mutant CFTR constructs, cRNA injection
in oocytes, two electrode voltage clamp assays and single channel
recordings were performed as previously described [14,15]. For single
channel recordings, only one patch per cell was studied, therefore, the
number of patches equals the number of cells studied. The open prob-
ability Po was calculated from Po = I/iN, where I is the averaged
current during the whole stimulation period, i the single channel cur-
rent obtained from amplitude histograms and N the number of chan-
nels estimated from overlapping events. All data were analyzed by
Student’s t-test. A value of P6 0.05 was considered signi¢cant. All
data are reported as mean þ S.E.M.
3. Results
3.1. Maturation of mutant CFTR proteins
The R628 mutation and the R1235 mutation, alone or in
combination with the R628 mutation, were introduced into
the CFTR coding region present in the eukaryotic expression
vector pcDNA3. Since the M470 allele causes a delay in mat-
uration and gives rise to a chloride channel with an increased
open probability, the R1235 mutation was introduced either
on a M470 or on a V470 background [11]. The di¡erent mu-
tant constructs were transfected in COS-1 cells and the ex-
pressed proteins were characterized by means of pulse chase
and immunoprecipitation experiments (Fig. 1). R1235 CFTR,
either on a V470 or on a M470 background, was found to
mature to the 190 kDa form. The R628 mutation, with or
without the R1235 mutation on the same allele, gave rise to
a protein of 150 kDa that was degraded; the mature 190 kDa
form could not be detected.
3.2. Electrophysiological characteristics of mutant CFTR
proteins
In order to study the e¡ect of the di¡erent amino acid
alterations on the electrophysiological characteristics of the
corresponding chloride channels, cAMP inducible whole cell
chloride currents in Xenopus laevis oocytes, injected with in
vitro transcribed cRNA, were analyzed using the two elec-
trode voltage clamp technique. The di¡erent studied CFTR
chloride channels had similar permeability properties (Fig.
2A,B). The mutant R1235-V (R1235 on a V470 background)
CFTR (0.39 þ 0.04 WA, n = 8) gave a signi¢cantly higher
cAMP sensitive whole cell current, when compared to
S1235-V (wildtype on a V470 background) CFTR
(0.16 þ 0.02 WA, n = 5; P6 0.001) (Fig. 2C). A slightly lower
whole cell current was observed for R1235-M (R1235 on a
M470 background) (0.36 þ 0.06 WA, n = 5), compared to the
R1235-V construct (0.39 þ 0.04 WA, n = 8); the di¡erence,
however, was not signi¢cant. The R1235-V (0.39 þ 0.04 WA,
n = 8) current was signi¢cantly reduced when R628 was
present (0.11 þ 0.01 WA, n = 9; P6 1035). Despite the fact
that R628 causes a maturation defect, cAMP induced chloride
currents measured for R628-V CFTR (0.19 þ 0.02 WA, n = 4)
were not signi¢cantly di¡erent from V470-wildtype CFTR
(0.16 þ 0.02 WA, n = 5). Indeed, overexpression of non-matur-
ing CFTR proteins in Xenopus oocytes, grown at room tem-
perature, can still result in the appearance of chloride chan-
nels at the cell surface. The amino acid present at residue 1235
a¡ected the chloride transport activity of the resulting R628
channels since R628/R1235-V induced a signi¢cantly lower
cAMP dependent chloride transport activity (0.11 þ 0.01 WA,
n = 9) than R628/S1235-V CFTR (0.19 þ 0.02 WA, n = 4;
P6 0.001). Since whole cell currents do not always correlate
with single channel activities of CFTR proteins, but are also
dependent on the number of chloride channels present in the
cell membrane, single channel measurements were set up. For
this purpose, COS-1 cells were transfected with bicistronic
constructs expressing both CFTR and the green £uorescent
protein from the same template. As a consequence, green £uo-
rescent cells that thus express CFTR could be selected under
the £uorescence microscope before they were patched. This
selection method is very useful, especially when CFTR chan-
nels with low intrinsic activities are studied. Only mutant pro-
teins with a normal maturation pattern, which are therefore
expected to be present in the cell membrane, were analyzed.
As a consequence the R628 mutants could not be analyzed at
the single channel level. Representative channel recordings are
shown in Fig. 3A. The di¡erent CFTR proteins had similar
conductive properties (Fig. 3B). The open probabilities of the
di¡erent CFTR proteins were determined (Fig. 3C). R1235-V
was found to exhibit a signi¢cantly higher open probability
(0.53 þ 0.09, n = 4) than S1235-V (V470-wildtype) CFTR
Fig. 1. Pulse chase and immunoprecipitation of CFTR from COS-1 cells transiently expressing V470-wildtype, pcDNA3 (empty vector), R628-
V, R628/R1235-V, R1235-V or R1235-M CFTR. Proteins were labelled with [35S]methionine and [35S]cysteine, chased for the indicated time pe-
riods and CFTR proteins were immunoprecipitated with an antibody directed against the C-terminal part of CFTR. The immunopuri¢ed pro-
teins were separated on a 4^12% SDS gel and visualized by autoradiography. The core glycosylated 150 kDa and the mature 190 kDa forms
are indicated.
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(0.23 þ 0.01, n = 4; P6 0.01). Since M470-wildtype CFTR
(0.45 þ 0.05, n = 6) has a signi¢cantly higher open probability
than V470-wildtype CFTR (0.23 þ 0.01, n = 4; P6 0.01), and
since R1235-V has still a higher open probability (Fig. 3),
even higher Po values were expected for R1235-M, compared
to R1235-V and S1235-M (M470 alone). Surprisingly, R1235
on a M470 background (0.31 þ 0.04, n = 6) gave rise to chlo-
ride channels with open probabilities not signi¢cantly di¡erent
from V470-wildtype (S1235) CFTR (0.23 þ 0.01, n = 4).
3.3. Frequency of R1235 in the general population
The R1235 mutation was analyzed by means of allele spe-
ci¢c oligonucleotide hybridization. R1235 was found twice
among 57 (0.035) normal CFTR genes derived from mothers
of CF patients, while it was not found at all among 58 normal
CFTR genes derived from fathers of CF patients. CFTR genes
derived from random individuals not related to CF patients
showed a frequency of 0.023 (3/128).
3.4. R1235 haplotype backgrounds
The haplotype backgrounds of six R1235 CFTR genes were
determined. Two R1235 CFTR genes were found on the nor-
mal CFTR alleles of CF mothers, one was found in a CF
patient who carried a second missense mutation G628R
(gCc) on the same allele [9], one was from a patient with
borderline sweat chloride values who was compound hetero-
zygote for R1235 and vF508, and two R1235 CFTR genes
were found in random individuals. All R1235 CFTR genes
carried a 12-7-M haplotype background, built up of the alleles
found at the (TG)m, Tn, and M470V polymorphic loci respec-
tively.
4. Discussion
When the maturation patterns of the di¡erent mutant
CFTR proteins (R628-V CFTR, R1235-M CFTR, R1235-V
CFTR and R1235/R628-V CFTR) were compared, R1235
caused no aberrant processing, independent of the amino
acid found at residue 470. R628-V gave rise to a protein
that only reaches the 150 kDa form, indicating that it is re-
tained in the endoplasmic reticulum. The allele present at the
S1235R locus could not bypass this maturation defect.
When the di¡erent protein variants were analyzed at the
electrophysiological level, R1235 induced a cAMP dependent
whole cell chloride current which was signi¢cantly higher than
wildtype CFTR, and this observation was independent of the
amino acid residue found at position 470. Single channel mea-
surements, however, indicated that R1235 induced a chloride
channel with a signi¢cantly higher open probability than wild-
type, when both carried V470. Very strikingly, when both
R1235 and M470 were present, no di¡erence with V470-wild-
type was found. Previous studies [11] showed that M470 gives
Fig. 2. Properties of whole cell chloride currents measured in Xeno-
pus laevis oocytes expressing wildtype CFTR and mutant CFTR
proteins. Xenopus laevis oocytes were injected with in vitro tran-
scribed wildtype CFTR (V470-WT and M470-WT) and mutant
CFTR RNA (R628-V (V470/R628/S1235), R1235-V (V470/G628/
R1235), R1235-M (M470/G628/R1235), R628/R1235-V (V470/R628/
R1235)) and the cAMP induced chloride currents were measured by
the two electrode voltage clamp technique 72 h later. A: I^V rela-
tionships obtained from oocytes expressing wildtype CFTR in ND-
96 solution or iodide substituted ND-96 solution after stimulation.
B: Comparison of the permeability ratios of wildtype and mutant
CFTR after anion substitution (n = 3 for each group). C: Whole cell
chloride currents after stimulation of oocytes expressing wildtype
and mutant CFTR. Mutants that showed a signi¢cantly di¡erent
cAMP dependent chloride current (P6 0.05), compared to wildtype
CFTR, are marked with an asterisk and the number of cells ana-
lyzed is indicated.
Fig. 3. Single channel properties of wildtype and mutant CFTR
chloride channels expressed in COS-1 cells. COS-1 cells were trans-
fected with a bicistronic construct of green £uorescent protein and
wildtype CFTR (V470-WT and M470-WT) or mutant CFTR
(R1235-V (V470/G628/R1235), R1235-M (M470/G628/R1235))
cDNA. Cells expressing the green £uorescent protein were selected
and used for single channel measurements. A: Single channel re-
cordings of wildtype and mutant CFTR in the cell attached con¢gu-
ration at a holding potential of 360 mV. The dotted line indicates
the closed level of the single channel. B: Comparison of channel
conductances between wildtype and mutant CFTR at 360 mV (the
number of cells patched is indicated in C). C: Pooled data to com-
pare open probabilities between wildtype and mutant CFTR at 360
mV. The number of channels was estimated by overlapping sweep
events. The number of cells patched is indicated.
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rise to a channel with a signi¢cantly increased open probabil-
ity, when compared to V470 CFTR. Thus, both variants
(M470 and R1235) give rise to ‘hyper’-active chloride chan-
nels when they are present on separate alleles, but induce a
channel with V470 characteristics when they are found on the
same allele. The ‘hyper’-active e¡ect of the two alleles (M470
and R1235) is thus suppressed when found in combination on
the same allele. This might indicate that both amino acids,
residue 470 located in the ¢rst nucleotide binding domain and
residue 1235 located in the second nucleotide binding domain,
interact with each other. They might therefore be involved in
the cross-talk between the two nucleotide binding domains, a
feature that plays a crucial role in the complex regulation of
the CFTR chloride channel [2]. An interaction between both
nucleotide binding domains might be supported by the whole
cell data obtained for the alleles at the G628R locus. This
amino acid alteration is located in the N-terminal part of
exon 13, i.e. that part of exon 13 that has been proposed to
form the C-terminal part of the ¢rst nucleotide binding do-
main [16^18]. The cAMP induced whole cell currents in Xeno-
pus oocytes measured for R628 CFTR were dependent on the
amino acid residue present at amino acid position 1235;
R1235 induced an apparent decrease in whole cell current of
R628-V CFTR. Since R628 causes a maturation defect in
COS-1 cells, no con¢rmation of these data at the single chan-
nel level could be obtained. Therefore, the latter data have to
be interpreted with caution.
In parents of CF patients, the R1235 mutation was only
found on maternal chromosomes, and not on paternal ones.
The di¡erence, however, was not signi¢cant. The absence of
R1235 on normal CFTR genes of fertile male CF carriers
might indicate that it could cause CBAVD when found in
compound heterozygosity with a severe CFTR mutation. It
is therefore interesting to note that CBAVD patients that
carry R1235 have been described [4].
Based on the functional studies, we have no evidence that
R1235 causes disease, since R1235 CFTR proteins are able to
transport chloride ions. We can, however, not exclude that the
regulatory interaction of CFTR with other proteins [19,20]
will be a¡ected by R1235, in this way causing disease. Poly-
morphic loci, such as (TG)m, Tn and M470V, have been
shown to a¡ect CFTR properties [11,21]. The six R1235
CFTR genes, derived either from patients or from healthy
individuals, however, were found to have an identical haplo-
type background ([TG]12-T7-M470). We have therefore no
evidence that R1235, on a particular haplotype background,
a¡ects chloride transport through CFTR and if it is involved
in disease; however, only a limited number of R1235 genes
were studied. The R1235 mutation was found to be associated
with the M allele at the M470V locus, leading to normal chlo-
ride channel activity (Fig. 3). Of all T7 alleles, the ones that
harbor allele 12 at the (TG)m locus will result in the lowest
amount of functional CFTR due to a higher proportion of
transcripts lacking exon 9 [11], which will not mature [22,23].
Individuals that harbor the R1235 allele may therefore also
have a smaller number of CFTR channels, because of the
alleles found at the (TG)m and Tn loci. They might therefore
be more susceptible to genetic and/or environmental modula-
tors that a¡ect the CFTR protein network and in this way
cause disease.
In conclusion, an important ¢nding of this study was that
the e¡ect of individual mutations/polymorphisms may not be
additive, but might even suppress each other. The defect
caused by speci¢c CFTR mutations found in patients might
therefore be dependent on the alleles present at di¡erent poly-
morphic CFTR loci. In order to be able to explain the phe-
notypes associated with speci¢c CFTR mutations, analysis of
the defects caused by these mutations, at the maturational and
electrophysiological levels, should be done on their proper
genetic background. Regrettably, the genetic backgrounds
are unknown for the majority of mutations.
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